Indeed, NR3C1/Glucocorticoid Receptor and TP53 signaling pathways were revealed as linked to depressive symptoms by an sPLS analysis using the 33 patients at baseline, and the involvement of these two upregulators were confirmed in the differential gene expression analysis comparing post-surgery versus baseline in MDD patients. This evidence concerns the gene NR3C1 and major depressive disorder.